| scholarly article | Q13442814 |
| P2093 | author name string | Buurman WA | |
| De Baetselier P | |||
| Carlier Y | |||
| Lucas R | |||
| Truyens C | |||
| Torrico F | |||
| P2860 | cites work | Effects of anti-TNF monoclonal antibody infusion in patients with hairy cell leukaemia | Q67540536 |
| Coculture of human peripheral blood mononuclear cells with Trypanosoma cruzi leads to proliferation of lymphocytes and cytokine production | Q67718772 | ||
| Recombinant tumor necrosis factor enhances macrophage destruction of Trypanosoma cruzi in the presence of bacterial endotoxin | Q68143448 | ||
| Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans | Q68385775 | ||
| Role of tumour necrosis factor in the enhanced sensitivity of mice to endotoxin after exposure to lead | Q69441475 | ||
| Prevention of human TNF-induced cutaneous Shwartzmann reaction and acute mortality in mice treated with anti-human TNF monoclonal antibodies | Q70176974 | ||
| Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists | Q70466614 | ||
| Effect of antitumour necrosis factor treatment on circulating tumour necrosis factor levels and mortality after surgery in jaundiced mice | Q70486158 | ||
| Influence of nephrectomy on tumor necrosis factor clearance in a murine model | Q70568914 | ||
| Effects of anti-interferon-gamma and anti-interleukin-6 antibodies in disease models in mice: antibodies as carriers of cytokines | Q72557383 | ||
| LPS-induced sTNF-receptor release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-gamma | Q72574710 | ||
| An essential role for ectodomain shedding in mammalian development | Q77544828 | ||
| Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor | Q24304040 | ||
| Characterization of tumor necrosis factor-deficient mice | Q28512785 | ||
| TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation | Q28513332 | ||
| Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes | Q28593744 | ||
| The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor | Q28610826 | ||
| Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice | Q29622922 | ||
| Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages | Q35457307 | ||
| Evidence for a protective role of tumor necrosis factor in the acute phase of Trypanosoma cruzi infection in mice. | Q35534763 | ||
| The pathophysiology of tumor necrosis factors | Q36135208 | ||
| Inflammatory cytokines | Q36731936 | ||
| Pregnancy and humoral immune response in mice chronically infected by Trypanosoma cruzi | Q37024246 | ||
| Trypanosoma cruzi infection in tumor necrosis factor receptor p55-deficient mice | Q39571751 | ||
| Interleukin-6 (IL-6) production in mice infected with Trypanosoma cruzi: effect of its paradoxical increase by anti-IL-6 monoclonal antibody treatment on infection and acute-phase and humoral immune responses | Q39859276 | ||
| Differential effect of isotype on efficacy of anti-tumor necrosis factor alpha chimeric antibodies in experimental septic shock | Q40703896 | ||
| Tumour necrosis factor (TNF) binding proteins (soluble TNF receptor forms) with possible roles in inflammation and malignancy | Q40770719 | ||
| Tumor necrosis factors: developments during the last decade. | Q41020160 | ||
| Soluble cytokine receptors: their roles in immunoregulation, disease, and therapy. | Q41096704 | ||
| Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages. | Q41104715 | ||
| Membrane tumor necrosis factor-alpha (TNF-alpha) expressed on HTLV-I-infected T cells mediates a costimulatory signal for B cell activation--characterization of membrane TNF-alpha | Q41132007 | ||
| Molecules and mechanisms operating in septic shock: lessons from knockout mice | Q41546333 | ||
| Cytokines and cachexia | Q41588874 | ||
| Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. | Q41617474 | ||
| Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism | Q41641701 | ||
| Generation and characterization of a neutralizing rat anti-rmTNF-alpha monoclonal antibody | Q41719152 | ||
| Trypanosoma cruzi: cytokine effects on macrophage trypanocidal activity | Q41902933 | ||
| Immune complex-mediated glomerulopathy in experimental Chagas' disease. | Q43479300 | ||
| Is TNF alpha involved in early susceptibility of Trypanosoma cruzi-infected C3H/He mice? | Q43510921 | ||
| The cachexia associated with Trypanosoma cruzi acute infection in mice is attenuated by anti-TNF-alpha, but not by anti-IL-6 or anti-IFN-gamma antibodies. | Q43602788 | ||
| Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections | Q48002147 | ||
| Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria | Q48037129 | ||
| Molecular Cloning and Expression of Human and Rat Tumor Necrosis Factor Receptor Chain (p60) and Its Soluble Derivative, Tumor Necrosis Factor-Binding Protein | Q48246983 | ||
| Crucial role of TNF receptor type 1 (p55), but not of TNF receptor type 2 (p75), in murine toxoplasmosis | Q48494599 | ||
| Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection. | Q52522603 | ||
| A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. | Q53438021 | ||
| Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: lack of association between susceptibility and type 2 cytokine production. | Q54154405 | ||
| IL-10 mediates susceptibility to Trypanosoma cruzi infection. | Q54193255 | ||
| Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. | Q54296214 | ||
| Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. | Q54729757 | ||
| IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi | Q58843169 | ||
| Administration of anti-CD3 monoclonal antibody during experimental Chagas' disease induces CD8+ cell-dependent lethal shock | Q58843475 | ||
| Effect of recombinant tumour necrosis factor on acute infection in mice with Toxoplasma gondii or Trypanosoma cruzi | Q58845289 | ||
| Tumour necrosis factor (cachectin) production during experimental Chagas' disease | Q58845646 | ||
| In vitro release of lymphotoxin by spleen cells from C3H/HEJ and C57BL/6 mice infected with Trypanosoma cruzi | Q58847382 | ||
| The effects of bacterial endotoxin on the infection of mice with Trypanosoma cruzi | Q58848881 | ||
| Soluble TNF and membrane TNF expressed on CD4+ T lymphocytes differ in their ability to activate macrophage antileishmanial defense | Q67514226 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Trypanosoma cruzi | Q150162 |
| P304 | page(s) | 5579-5586 | |
| P577 | publication date | 1999-11-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | The endogenous balance of soluble tumor necrosis factor receptors and tumor necrosis factor modulates cachexia and mortality in mice acutely infected with Trypanosoma cruzi | |
| P478 | volume | 67 |
| Q35747668 | Acute Trypanosoma cruzi infection in mouse induces infertility or placental parasite invasion and ischemic necrosis associated with massive fetal loss |
| Q34561893 | Adaptive immunity alters distinct host feeding pathways during nematode induced inflammation, a novel mechanism in parasite expulsion. |
| Q34193529 | Different infective forms trigger distinct immune response in experimental Chagas disease |
| Q58846223 | Differential susceptibility to acute Trypanosoma cruzi infection in BALB/c and C57BL/6 mice is not associated with a distinct parasite load but cytokine abnormalities |
| Q33655042 | Etanercept induces low QRS voltage and autonomic dysfunction in mice with experimental Chagas disease. |
| Q35607372 | Infertility in murine acute Trypanosoma cruzi infection is associated with inhibition of pre-implantation embryo development |
| Q33600538 | Maternal Trypanosoma cruzi infection upregulates capacity of uninfected neonate cells To produce pro- and anti-inflammatory cytokines |
| Q40763872 | Proinflammatory cytokine expression in the early phase of Trypanosoma brucei rhodesiense infection in vervet monkeys (Cercopithecus aethiops). |
| Q38726867 | TNF Lectin-Like Domain Restores Epithelial Sodium Channel Function in Frameshift Mutants Associated with Pseudohypoaldosteronism Type 1B |
| Q37406176 | The Ly49E Receptor Inhibits the Immune Control of Acute Trypanosoma cruzi Infection. |
| Q33597343 | Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice |
| Q36793292 | Tumor necrosis factor inhibitors for the treatment of asthma |
| Q34032964 | Tumor necrosis factor is a therapeutic target for immunological unbalance and cardiac abnormalities in chronic experimental Chagas' heart disease. |
Search more.